Status:
COMPLETED
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
Lead Sponsor:
Vanderbilt University
Conditions:
Head and Neck Neoplasms
Fibrosis
Eligibility:
All Genders
21+ years
Brief Summary
Goal: The primary goal of this study is to longitudinally investigate, in head and neck cancer (HNC) patients, the potential fibrosis-lymphedema continuum. Specifically, we will examine the developme...
Detailed Description
Background: The use of aggressive treatment for HNC, particularly combined modality treatment regimens has resulted in an increase in survival. Unfortunately, this improvement has come with a marked i...
Eligibility Criteria
Inclusion
- newly diagnosed, histologically proven carcinoma involving the head and neck
- Stage II or greater
- age of 21 or over
- willing and able to undergo baseline and follow-up assessment at the VICC Nashville, or the Nashville Veterans Administration Medical Center (Nashville VA
- the ability to speak English
Exclusion
- medical record documentation of cognitive impairment that would preclude the ability to provide informed consent
- unwilling to undergo routine follow-up at VICC Nashville or the Nashville VA
- recurrent cancer
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01187173
Start Date
July 1 2010
End Date
November 1 2014
Last Update
April 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Ingram Cancer Center
Nashville, Tennessee, United States, 37232